Publication

Article

Pharmaceutical Executive

Pharmaceutical Executive-06-01-2022
Volume42
Issue 6

Pharmaceutical Executive, June 2022 Issue (PDF)

Click cover to access PDF

Download Issue PDF
Articles in this issue
Pharmaceutical Executive, June 2022 Issue (PDF)
Pharmaceutical Executive, June 2022 Issue (PDF)
2022 Pharm Exec Top 50 Companies
2022 Pharm Exec Top 50 Companies
The Emergence of the Chief Value Officer in Healthcare
The Emergence of the Chief Value Officer in Healthcare
Sustainability Sea Change: The Top 5 ESG Challenges for Pharma
Sustainability Sea Change: The Top 5 ESG Challenges for Pharma
Is the C-Suite Getting Inflated?
Clinical Composer
Clinical Composer

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Helen Sabzevari
Pharmaceutical Executive
Helen Sabzevari
Related Content
Stock.adobe.com
September 12th 2025

White House Officials Drafting Executive Order Enforcing Harsh Restrictions on Treatments Discovered in China: Report

Nicholas Jacobus
Pharmaceutical Executive
September 12th 2025

Pharmaceutical Executive Daily: September 11, 2025

Nicholas Jacobus
Stock.adobe.com
September 12th 2025

Intercept Pharmaceuticals Withdraws Ocaliva from Shelves Following U.S. Regulator’s Request

Nicholas Jacobus
Pharmaceutical Executive
September 12th 2025

Pharmaceutical Executive Daily: September 9, 2025

Nicholas Jacobus
Pharm Exec MFN webinar
September 12th 2025

What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients

Mike Hollan
David Bell
September 12th 2025

The Strategies Behind Bringing a Novel Therapy to Market Successfully

David Bell
© 2025 MJH Life Sciences

All rights reserved.